NeoMend Garners $30,000,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a45241b9-1d8c-4746-a1fc-d5bc194a5a2e&Preview=1 -
Date
1/27/2010 -
Company Name
NeoMend -
Mailing Address
60 Technology Drive Irvine, CA 92618 -
Company Description
NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products. -
Website
http://www.neomendinc.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
This new funding will move Neomend toward cash flow break-even, as we also pursue approvals for other applications of ProGEL. -
M&A Terms
-
Venture Investor
Clarus Ventures -
Venture Investor
Novo A/S -
Venture Investor
Vivo Ventures -
Venture Investor
Sanderling Ventures -
Venture Investor
Prospect Venture Partners
